Cargando…

The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells

BACKGROUND: The introduction of specific BCR-ABL inhibitors in chronic myelogenous leukemia therapy has entirely mutated the prognosis of this hematologic cancer from being a fatal disorder to becoming a chronic disease. Due to the probable long lasting treatment with tyrosine-kinase inhibitors (TKI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borriello, Adriana, Caldarelli, Ilaria, Basile, Maria Assunta, Bencivenga, Debora, Tramontano, Annunziata, Perrotta, Silverio, Ragione, Fulvio Della, Oliva, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229607/ https://www.ncbi.nlm.nih.gov/pubmed/22164306 http://dx.doi.org/10.1371/journal.pone.0028555

Ejemplares similares

Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions
por: Borriello, Adriana, et al.
Publicado: (2016)

A cancer‐associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss‐of‐function
por: Bencivenga, Debora, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation
por: Borriello, Adriana, et al.
Publicado: (2016)

Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases
por: Stampone, Emanuela, et al.
Publicado: (2018)

Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
por: Stampone, Emanuela, et al.
Publicado: (2023)

p27(Kip1), an Intrinsically Unstructured Protein with Scaffold Properties
por: Bencivenga, Debora, et al.
Publicado: (2021)

Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
por: Campana, Pasquale, et al.
Publicado: (2020)

An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs
por: Bencivenga, Debora, et al.
Publicado: (2022)

A Beckwith–Wiedemann-Associated CDKN1C Mutation Allows the Identification of a Novel Nuclear Localization Signal in Human p57(Kip2)
por: Stampone, Emanuela, et al.
Publicado: (2021)

High Dosage Lithium Treatment Induces DNA Damage and p57(Kip2) Decrease
por: Stampone, Emanuela, et al.
Publicado: (2020)

EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34(+) Cell Differentiation and Increases Circulating Endothelial Precursors
por: Perrotta, Silverio, et al.
Publicado: (2010)

Hypocalcemia: A key biomarker in hospitalized COVID-19 patients
por: Ruiz-Álvarez, María Jesús, et al.
Publicado: (2023)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
por: El-Dabh, Ashraf, et al.
Publicado: (2019)

Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiation
por: Prideaux, Matthew, et al.
Publicado: (2021)

The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation
por: Vandyke, K, et al.
Publicado: (2011)

LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies
por: Santoro, Claudia, et al.
Publicado: (2014)

A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme
por: Nehoff, Hayley, et al.
Publicado: (2015)

Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis
por: Guo, Kai, et al.
Publicado: (2019)

Zinc finger factor 521 enhances adipogenic differentiation of mouse multipotent cells and human bone marrow mesenchymal stem cells
por: Tseng, Kuo-Yun, et al.
Publicado: (2015)

Zinc finger protein ZFP36L1 promotes osteoblastic differentiation but represses adipogenic differentiation of mouse multipotent cells
por: Tseng, Kuo-Yun, et al.
Publicado: (2017)

Alteration of active and repressive histone marks during adipogenic differentiation of porcine mesenchymal stem cells
por: Stachecka, Joanna, et al.
Publicado: (2021)

Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene
por: Punzo, Francesca, et al.
Publicado: (2011)

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
por: Hennigs, Jan K, et al.
Publicado: (2011)

Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
por: Liu, Yuanbo, et al.
Publicado: (2010)

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022)

Dasatinib-Induced Chylothorax Beyond 5 Years of Treatment: Is There Actually Any Limit?
por: Garcia-Zamalloa, Alberto, et al.
Publicado: (2023)

Dasatinib has a dual effect on sepsis
por: Gonçalves-deAlbuquerque, Cassiano F, et al.
Publicado: (2013)

Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
por: Chang, Q, et al.
Publicado: (2008)

Stable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties
por: Saladi, Venkata Narasayya, et al.
Publicado: (2022)

The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice
por: Gu, Yue, et al.
Publicado: (2023)

Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A(1) Receptor Ligands
por: Zuccarini, Mariachiara, et al.
Publicado: (2021)

Myocardial Ischemic Subject’s Thymus Fat: A Novel Source of Multipotent Stromal Cells
por: Oliva-Olivera, Wilfredo, et al.
Publicado: (2015)

Dasatinib-Related Chylothorax
por: Huang, Yen-Min, et al.
Publicado: (2015)

DASATINIB-RELATED CHYLOTHORAX
por: Young, Katherine, et al.
Publicado: (2019)

Human adipose tissue H3K4me3 histone mark in adipogenic, lipid metabolism and inflammatory genes is positively associated with BMI and HOMA-IR
por: Castellano-Castillo, Daniel, et al.
Publicado: (2019)

Bisphenol A Diglycidyl Ether Induces Adipogenic Differentiation of Multipotent Stromal Stem Cells through a Peroxisome Proliferator–Activated Receptor Gamma-Independent Mechanism
por: Chamorro-García, Raquel, et al.
Publicado: (2012)

Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines
por: Lu, Liu, et al.
Publicado: (2018)

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging
por: Rodríguez-Agustín, Andrea, et al.
Publicado: (2023)

RPTPμ tyrosine phosphatase promotes adipogenic differentiation via modulation of p120 catenin phosphorylation
por: Kim, Won Kon, et al.
Publicado: (2011)

Protein tyrosine phosphatase profiling studies during brown adipogenic differentiation of mouse primary brown preadipocytes
por: Choi, Hye-Ryung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j9t269hglpf9r0nihsneo2nqqv